Application no. and date | 07866627.8 (espacenet) (Federated) (European Patent Register), 20071128 | Patent/reg. no. and date | DK/EP 2092069, 20110511 | Publication date | 20090826 | Priority no. and date | EP 06291824, 20061128, EP 07290042, 20070111 | EP pub. no. and date |
EP 2092069 20090826 | Effective date | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | Applicant ref. no. | AVENT FR2006/084 | Inventor | NESBIT, Mark, Sanofi-aventis 174 avenue de France
75013 Paris, FR, CAMERON, Béatrice, Sanofi-aventis 174 avenue de France
75013 Paris, FR, BLANCHE, Francis, Sanofi-aventis 174 avenue de France
75013 Paris, FR, SORDELLO, Sylvie, Sanofi-aventis 174 avenue de France
75013 Paris, FR, NICOLAZZI, Céline, Sanofi-aventis 174 avenue de France
75013 Paris, FR, TROMBE, Marc, Sanofi-aventis 174 avenue de France
75013 Paris, FR | Representative | | Opponent | | IPC Class | A61K 38/17 (2006.01) , A61K 47/48 (2006.01) , C07K 14/47 (2006.01) , C07K 14/71 (2006.01) , C12N 15/62 (2006.01) | Title | Modificerede opløselige fgf-receptor fc-fusioner med forbedret biologisk aktivitet | Int. application no. | IB2007004354 | Int. publication no. | WO2008065543 | Related patent (certificate) | | Status | Ændret EP patent ikke valid i DK | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|